ELEVATE SHINES BRIGHT WITH 2 GOLD WINS AT THE 2023 PM360 PHARMA CHOICE AWARDS
From day one, Elevate has set out to produce impactful and innovative work, continually aiming to raise the standards of creative excellence. That mission bears fruit once again, as the industry has recognized Elevate with 2 gold wins at the 2023 PM360 Pharma Choice Awards.
Elevate is excited to announce that the “Danger Lurks Below the Surface” campaign for topical and photodynamic therapy AMELUZ® and the “See More. Resect More.” campaign for innovative imaging agent Gleolan® have both struck Pharma Choice gold wins. The Pharma Choice awards are distinct, as the judging is done by healthcare marketing colleagues, which makes it a special achievement. All submissions are placed online where anyone in the industry can vote for their favorites based on content, format, imagination, influence on the industry, impact on the audience, and overall quality. This year, more than 8500 votes were cast.
Frank X. Powers, Elevate co-founder and managing partner, said, “Recognition from the healthcare industry as a whole truly shows the impact innovative marketing has, as everyone voting in these awards know the challenges of delivering breakthrough, memorable, and creative solutions.”
For the AMELUZ campaign, winning gold in the Consumer Website category at this year’s Pharma Choice awards carries particular meaning because the campaign was one of the submissions with the highest number of votes, and because of that a representative from the brand team will be featured on the cover of the issue. Leslie Hopkins, Associate Director of Marketing at Biofrontera, is the easy choice to be featured. Her leadership skills, attention to detail, and strategic vision for the brand helped to significantly increase sales revenue in 2021 and 2022, while transforming the dermatology market landscape.
The “See More. Resect More” campaign winning gold for Professional Campaign aims to shine a light on the innovative benefit Gleolan offers healthcare providers in visualizing malignancies. Products this innovative need brand imagery just as innovative to shine. With breakthrough strategy and execution, this campaign finds itself in the spotlight, and the entire team couldn’t be prouder.
Elevate is proud of and thankful for the AMELUZ and Gleolan client and agency teams for their dedication and hard work. You can see all the winning work in the January/February 2023 issue of PM360, or view it here.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.